Wix.com is navigating one of its sharpest drawdowns in recent memory, with the stock off 40% in a month and analysts in near-universal retreat — yet short positioning tells a more nuanced story than the price action alone suggests.
The most striking feature of this week's setup is the scale and uniformity of analyst capitulation. Every firm that moved on WIX in the past 48 hours lowered its price target, and none upgraded their rating. UBS cut its target to $58 from $68 on Tuesday while staying Neutral. Wells Fargo trimmed to $47 from $54, holding Equal-Weight. Citi dropped to $59 from $66. RBC cut the most aggressively among the sideline names, moving to $45 from $60. Scotiabank and B. Riley also reduced targets on Monday, with B. Riley maintaining its Buy but pulling the target down to $135 from $150 — a level that now looks detached from the stock's $48.22 close. The consensus mean price target of $81.63 implies around 69% upside on paper, but that figure is heavily anchored by bullish holdouts writing targets above $100; the floor of active estimates is now below the current price. The pattern is one of a Street scrambling to reset after an earnings shock rather than a considered revaluation.
The root cause was the May 13 earnings print, which sent WIX down 30.5% in a single session and a further 27.8% over the following five days — the most severe earnings reaction in the data. The bear case has hardened around three concerns: AI disruption to the core web-creation product, gross margin degradation in guidance, and a slowdown in premium subscriber additions. The bull case rests on partner revenue hitting $203 million, Base44 ARR approaching the $100 million milestone, and a payments business growing in scale. The PE multiple has compressed to 7.8x trailing earnings, down nearly 3.8 turns in a month — cheap by historical standards for a company still growing revenue, but the market is questioning the durability of that growth.
Short positioning is elevated but not spiralling higher — a subtle but important distinction. Short interest has held close to 15.6% of free float all month, moving in a narrow band between roughly 8.1 and 8.9 million shares and ending the week at 8.54 million, barely changed from four weeks ago. The ORTEX short score has been pinned near 70 for two weeks, placing WIX in the top tier of bearish positioning across the software universe. What's changed this week is the borrow dynamic: availability loosened sharply, jumping 35% week-on-week to 61%, after spending most of May between 30% and 40%. Cost to borrow has also fallen 22% over the week to 0.69% — the lowest level in the 30-day window. That combination — high short interest but loosening borrow conditions — reads as shorts staying put rather than pressing new positions. The ORTEX short score ranking in the 5th percentile confirms the bearish lean is structural, but the ease in borrow suggests no new wave of conviction shorting this week.
Options positioning is muted relative to the drama in the underlying. The put/call ratio runs at 0.93, only marginally above its 20-day average of 0.91 and just 0.4 standard deviations elevated — well within normal range and nowhere near the 52-week high of 2.37 recorded during earlier stress periods. That relative calm in options contrasts with the price damage: investors appear to have already absorbed the downside via the stock itself rather than through protective puts. EPS momentum factor scores sit at the 9th and 14th percentiles on the 30- and 90-day windows respectively, confirming the estimate revision cycle has been decidedly negative, while the EPS surprise score at the 10th percentile reflects how badly the last quarter missed expectations.
On the institutional side, Columbia Management stands out — the largest holder added over 4.6 million shares as of May 31, lifting its stake to 27.3% of shares outstanding. That is an extraordinarily concentrated position for a single asset manager and represents a meaningful vote of confidence even as the rest of the Street retrenches. Aristeia Capital and Durable Capital both appear to have initiated positions in Q1, according to the most recent filings.
The next scheduled catalyst is the Q2 earnings release on August 5. Between now and then, the question is whether the revised analyst targets — now clustered between $45 and $90 — begin to stabilise or continue drifting lower as macro and AI headwinds are reassessed.
See the live data behind this article on ORTEX.
Open WIX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
